Every open market buy and sale of MBX Biosciences, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $526K bought and $3M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when MBX insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an MBX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
MBX cluster buys
All MBX cluster buys →- 3 insiders bought $12.5MTrades Sep 26, 2025 to Oct 20, 2025 · public Oct 20, 2025
A cluster buy is two or more insiders buying on the open market within 30 days of each other.
Every MBX insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Steven L. HoerterChairman, President and CEO | Sale | 4,893 | $54.82 | $268K | 78,045 | Nov 12Form 4 |
| Nov 4, 2026 | Salomon AzoulayChief Medical Officer | Sale | 373 | $53.96 | $20K | 14,026 | Nov 5Form 4 |
| Aug 4, 2026 | Salomon AzoulayChief Medical Officer | Sale | 370 | $65.77 | $24K | 14,399 | Aug 5Form 4 |
| May 8, 2026 | Salomon AzoulayChief Medical Officer | Sale plan | 70,003 | $38.36 | $2.7M | 14,769 | May 11Form 4 |
| May 6, 2026 | P. Kent HawrylukPresident & CEO | Sale | 607 | $29.54 | $18K | 727,667 | May 8Form 4 |
| May 6, 2026 | Salomon AzoulayChief Medical Officer | Sale | 231 | $29.54 | $7K | 14,769 | May 8Form 4 |
| Mar 13, 2026 | P. Kent HawrylukPresident & CEO | Buy | 18,500 | $28.41 | $526K | 486,777 | Mar 16Form 4 |
| Oct 20, 2025 | P. Kent HawrylukPresident & CEO | Buy | 20,000 | $13.64 | $273K | 468,277 | Oct 21Form 4 |
| Oct 17, 2025 | Steven L. HoerterDirector | Buy | 20,000 | $13.25 | $265K | 20,000 | Oct 20Form 4 |
| Sep 26, 2025 | Fhmls X, L.P.10% owner | Buy | 666,666 | $18.00 | $12M | 5,219,440 | Sep 30Form 4 |
| Apr 8, 2025 | Ora H. PescovitzDirector | Buy | 7,693 | $5.89 | $45K | 24,329 | Apr 10Form 4 |
| Feb 18, 2025 | OrbiMed Genesis GP LLCDirector | Buy | 190,672 | $10.60 | $2M | 747,887 | Feb 19Form 4 |
| Feb 18, 2025 | Carl L GordonDirector | Buy | 190,672 | $10.60 | $2M | 747,887 | Feb 19Form 4 |
| Feb 4, 2025 | P. Kent HawrylukPresident & CEO | Buy | 50,000 | $10.69 | $535K | 448,277 | Feb 5Form 4 |
MBX insider trading FAQ
Are MBX insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $526K of MBX on the open market in 1 trades, and 3 sold $3M in 6 trades, 89% of that under pre-arranged trading plans.
When did an MBX insider last buy shares?
P. Kent Hawryluk (President & CEO) bought 18,500 shares for $526K on Mar 13, 2026, reported on Mar 16, 2026.
When did an MBX insider last sell shares?
Steven L. Hoerter (Chairman, President and CEO) sold 4,893 shares for $268K on Nov 10, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
